American Journal of Obstetrics & Gynecology Mfm最新文献

{"title":"Maternal cholesterol matters: it is time for routine monitoring","authors":"Amanda A. de Oliveira PhD , Christy-Lynn M. Cooke MD, PhD , Sandra T. Davidge PhD","doi":"10.1016/j.ajogmf.2025.101684","DOIUrl":"10.1016/j.ajogmf.2025.101684","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":"7 7","pages":"Article 101684"},"PeriodicalIF":3.8,"publicationDate":"2025-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144147552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Developing a Novel Patient-Centered Definition of Severe Maternal Morbidity.","authors":"Adina R Kern-Goldberger, Lauren E Callans, Rebecca F Hamm, Lisa D Levine","doi":"10.1016/j.ajogmf.2025.101706","DOIUrl":"https://doi.org/10.1016/j.ajogmf.2025.101706","url":null,"abstract":"<p><strong>Background: </strong>Defining, preventing, and evaluating severe maternal morbidity (SMM) has become an important component of obstetric care delivery, but existing frameworks for SMM do not account for how patients perceive and experience morbidity.</p><p><strong>Objective: </strong>This study evaluated patient values and perceptions related to maternal pregnancy complications with the goal of devising a patient-centered maternal morbidity composite.</p><p><strong>Study design: </strong>This 2-part sequential qualitative to quantitative mixed-methods study first involved semi-structured interviews of postpartum patients recruited from an urban, academic hospital prior to discharge from the delivery admission with purposive sampling by race and mode of delivery. Qualitative data around patient-perceived adverse maternal events were analyzed thematically. These themes were used to develop a survey which prompted ranking the maternal complications derived from these interview data as well as the SMM indicators defined by the Centers for Disease Control and Prevention (CDC) on a scale from 1 [\"no big deal\"] - 5 [\"worst thing imaginable\"]. Responses were compared in bivariate analyses among patients who did and did not personally experience an expanded maternal morbidity composite inclusive of SMM as well as postpartum hemorrhage, re-operation, intensive care unit admission, and endometritis/post-operative infection. All postpartum patients were eligible to participate and recruited participants completed the survey prior to discharge.</p><p><strong>Results: </strong>18 patients participated in the semi-structured interviews with 9 themes identified distinct from established SMM criteria. 501 patients then completed the survey over 5 months (6/2022 - 11/2022). 60.7% of participants were Black, 6.5% were Hispanic, median maternal age was 31 [IQR 26-34], 40.6% underwent cesarean delivery, 6% experienced a postpartum hemorrhage, and 1.6% (N = 8) experienced non-transfusion SMM as defined by the CDC. The 3 maternal morbidity outcomes ranked by patients as \"worst\" were stroke/seizure, hysterectomy, and heart failure. Other notable findings included that 66.3% of patients ranked severe postpartum depression as a 4 or 5, higher than hemorrhage, transfusion, and long-term physical disability. There were no significant differences in scoring of maternal morbidity types among patients who did and did not personally experience morbidity.</p><p><strong>Conclusion: </strong>Adverse maternal outcomes important to patients do not correlate directly with established SMM composites. Novel definitions of maternal morbidity incorporating expanded indicators such as severe depression could fuel a patient-centered approach to evaluating and mitigating SMM in research and clinical care.</p>","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":" ","pages":"101706"},"PeriodicalIF":3.8,"publicationDate":"2025-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144162670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Hemoglobin A1c among patients without diabetes and risk of large for gestational age neonates.","authors":"Ximena A VAN Tienhoven, Kelly Zafman, Whitney R Bender, Celeste Durnwald","doi":"10.1016/j.ajogmf.2025.101710","DOIUrl":"https://doi.org/10.1016/j.ajogmf.2025.101710","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":" ","pages":"101710"},"PeriodicalIF":3.8,"publicationDate":"2025-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144152145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Antenatal corticosteroids for patients at risk of late preterm birth: a systematic review and meta-analysis of randomized controlled trials.","authors":"Fabrizio Zullo, Moti Gulersen, Daniele Di Mascio, Stephanie C Roth, Teresa C Logue, Giuseppe Rizzo, Antonella Giancotti, Hector Mendez Figueroa, Anthony C Sciscione, Gabriele Saccone, Suneet P Chauhan, Vincenzo Berghella","doi":"10.1016/j.ajogmf.2025.101709","DOIUrl":"https://doi.org/10.1016/j.ajogmf.2025.101709","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To evaluate the effectiveness of antenatal corticosteroid administration in the late preterm period (34 0/7- 36 6/7 weeks of gestation).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Data sources: &lt;/strong&gt;A Medical Librarian performed a search in the following databases and grey literature sources from inception until July 15, 2024: PubMed (NLM), Embase.com (Elsevier), Scopus (Elsevier), Cochrane CENTRAL (Wiley), CINAHL Ultimate (EBSCOHost), ClinicalTrials.gov and WHO ICTRP.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Eligibility criteria for selecting studies: &lt;/strong&gt;This study screened studies using two independent reviewers based on the predefined inclusion/exclusions criteria. This study included randomized controlled trials (RCTs) comparing antenatal corticosteroid administration with placebo or with no treatment given to individuals with singleton gestations at 34 0/7 - 36 6/7 weeks.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Study appraisal and synthesis methods: &lt;/strong&gt;This study appraised the included randomized controlled trials using two independent reviewers based on the Cochrane RoB 2 tool and other assessment measures. The primary outcome was the incidence of respiratory distress syndrome (RDS) (6 trials, 5163 newborns). Secondary outcomes included hypoglycemia (as defined by each trial) (4 trials, 4750 newborns), incidence of transient tachypnea of the newborn (TTN) (4 trials, 4292 newborns), neonatal intensive care unit (NICU) admission (6 trials, 5169 newborns), continuous positive airway pressure (CPAP) use for ≥2 hours (4 trials, 4760 newborns), surfactant administration (2 trials, 3100 newborns), neonatal sepsis (4 trials, 4754 newborns), neonatal mortality (5 trials, 4920 newborns), need for resuscitation in the labor suite (4 trials, 4647 newborns), hyperbilirubinemia (2 trials, 1156 newborns), necrotizing enterocolitis (NEC) (2 trials, 3710 newborns), mechanical ventilation (5 trials, 5069 newborns) and Apgar Score at 5 minutes of life (2 trials) and maternal outcomes. The summary measures were reported as relative risk (RR) or as mean difference (MD) with 95% of confidence interval (CI) using the random effects model of DerSimonian and Laird. I-squared(Higgins I&lt;sup&gt;2&lt;/sup&gt;) greater than 0% was used to identify heterogeneity.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Six RCTs, encompassing 5,143 deliveries, were included for analysis. The incidence of RDS was similar in the two groups (RR 1.03, 95% CI 0.73-1.45), as was the rate of transient tachypnea of the newborn (TTN) (RR 0.93, 95% CI 0.67-1.29). Antenatal corticosteroids significantly reduced the use of CPAP ≥ 2 hours (RR 0.78, 95% CI 0.65-0.94; p= 0.007) and surfactant (RR 0.61, 95% CI 0.38-0.99; p= 0.04) compared to the control. There were no significant differences in mechanical ventilation (RR 0.75, 95% CI 0.51-1.11), NICU admission rate (RR 0.94, 95% CI 0.84-1.05), hypoglycemia (RR 1.28 95% CI 0.93-1.74) neonatal death (RR 0.94, 95% CI 0.34-2.63), Apgar Score at 5 min (MD -0.07 95% CI 95% -0.17-0.03) compared between the two g","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":" ","pages":"101709"},"PeriodicalIF":3.8,"publicationDate":"2025-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144152142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Propranolol to decrease time to delivery: a meta-analysis of randomized controlled trials.","authors":"Sonia Biswas, Mariella Toro, Rebecca Horgan, Rodney A McLaren, Vincenzo Berghella, Huda B Al-Kouatly","doi":"10.1016/j.ajogmf.2025.101705","DOIUrl":"https://doi.org/10.1016/j.ajogmf.2025.101705","url":null,"abstract":"<p><strong>Objective: </strong>To assess the effect of propranolol on time to delivery among patients undergoing induction or augmentation of labor.</p><p><strong>Data sources: </strong>PubMed, Scopus, Cochrane Library, ClinicalTrials.gov, and CINAHL (EBSCO) were searched from inception to December 2023.</p><p><strong>Study eligibility criteria: </strong>Randomized controlled trials (RCTs) that examined the impact of propranolol on time to delivery among patients undergoing induction or augmentation of labor were included. RCTs that included stillbirth before randomization, non-randomized trials, observational, cohort, case control, or studies in which the control group included an intervention other than standard care were excluded.</p><p><strong>Study appraisal and synthesis methods: </strong>Primary outcome was time to delivery after administration of propranolol among patients undergoing induction or augmentation of labor. The summary measures were reported as summary mean difference (MD) or relative risk with 95% of confidence interval (CI).</p><p><strong>Results: </strong>Five RCTs including 660 patients were included in this meta-analysis. One study investigated the effect of propranolol compared to placebo among patients undergoing induction of labor (IOL) and did not demonstrate a significant decrease in time to delivery (828 minutes ± 324 vs 858 minutes ± 318, p=0.48). Four studies investigated the effect of propranolol among patients undergoing augmentation of labor and showed no significant decrease in time to delivery (MD, -2.98 minutes, 95% CI -21.6 to 15.6). Our pooled analysis demonstrated that the use of propranolol in IOL and augmentation was not associated with a decrease in time to delivery from administration of propranolol compared to placebo (mean difference, -4.33 minutes, 95% CI -22.48 to 13.83). The meta-analysis found no increased risk of PPH, blood transfusion, cesarean delivery rates, or NICU admission with the use of propranolol during labor.</p><p><strong>Conclusion: </strong>The use of propranolol during induction and augmentation of labor did not significantly decrease time to delivery.</p>","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":" ","pages":"101705"},"PeriodicalIF":3.8,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144143825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Perinatal Outcomes of Cystic Hygroma: A Systematic Review and Meta-Analysis: Running Head: Systematic Review of Cystic Hygroma Outcomes.","authors":"Michelle J Wang, Maria Bazan, Tina Hsieh, Carol Mita, Millie A Ferrés, Yinka Oyelese","doi":"10.1016/j.ajogmf.2025.101704","DOIUrl":"https://doi.org/10.1016/j.ajogmf.2025.101704","url":null,"abstract":"<p><strong>Objectives: </strong>The aim of this systematic review and meta-analysis was to describe the perinatal outcomes and modifiers of antenatally diagnosed cystic hygroma (CH).</p><p><strong>Data sources: </strong>The PubMed, Embase and Web of Science Core Collection databases were searched from inception until March 18, 2024.</p><p><strong>Study eligibility criteria: </strong>Full-text English-language observational cohort studies reporting any pregnancy and postnatal outcomes for fetuses with a CH diagnosed on prenatal ultrasound were included in this study.</p><p><strong>Methods: </strong>The primary outcome was the incidence of genetic diagnosis and incidence of major structural anomalies. Secondary outcomes included the incidence of perinatal loss, termination of pregnancy, CH resolution, live birth rate and normal postnatal outcomes. Stratified analyses were conducted of cases diagnosed in the first trimester as well as all cases with septations as part of diagnostic criteria. Pooled proportions were calculated for the different outcomes.</p><p><strong>Results: </strong>Fifty-seven studies met inclusion criteria (including 4693 cases of CH); these were cohort studies that included any of our primary search outcomes. The pooled prevalence of genetic diagnosis (56 studies, 3837 fetuses) was 55% (95% CI, 0.51-0.58). For specific aneuploidies, the pooled prevalence was 21% for Turner syndrome, 17% for Trisomy 21, 10% for Trisomy 18, 3% for Trisomy 13, and 5% for other genetic diagnoses. The overall pooled prevalence of major structural anomalies (30 studies, 1987 fetuses) was 42%; across 16 studies (1815 fetuses), 16% of fetuses with CH and an additional structural abnormality had no identified genetic diagnosis. Furthermore, 20% of all CH regressed or resolved during the pregnancy. The findings from the studies that that defined CH by the presence of septations, as well as those focusing solely on first trimester CH were consistent with the overall outcomes.</p><p><strong>Conclusions: </strong>Our findings confirm that while CHs have a strong association with common trisomies and Turner syndrome, there is a proportion of cases with non-aneuploidy genetic diagnoses. Forty percent of cases are also associated with other structural anomalies that may be able to be elicited with a detailed first trimester anatomic ultrasound. Further studies should explore modifiers of CH outcomes to allow for more accurate and tailored patient counseling.</p>","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":" ","pages":"101704"},"PeriodicalIF":3.8,"publicationDate":"2025-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144102834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Meaningful clinical outcomes: perspectives of primary caregivers with lived experience of spontaneous preterm birth following spontaneous preterm labor.","authors":"Elizabeth Gargon, Rosie Sharp, Laura Grant, Anya Francis, Damien J Croft, Edith Roset Bahmanyar, Kara M Rood, Vanessa Perez Patel","doi":"10.1016/j.ajogmf.2025.101701","DOIUrl":"https://doi.org/10.1016/j.ajogmf.2025.101701","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Patient-centered research is foundational to informing the measurement of clinical benefit in interventional studies. Understanding caregivers' lived experience of spontaneous preterm birth (sPTB) resulting from spontaneous preterm labor (sPTL) and characterizing their perspectives on the clinical outcomes of greatest importance and relevance are essential for advancing the development of interventions for the delay or prevention of sPTB.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;This mixed methods study aimed to identify which clinical outcomes deriving from a (hypothetical) successful sPTL intervention are most important and relevant from the caregiver perspective to advance the therapeutic landscape for sPTB resulting from sPTL.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Study design: &lt;/strong&gt;A targeted literature review was conducted to obtain preliminary insights, which informed the content of semi-structured, qualitative, concept elicitation telephone interviews with primary caregivers in the United States who had a live, singleton sPTB between 23 and 36 weeks' gestational age resulting from sPTL. Primary caregivers were those who self-identified as the parent who gave birth to the child preterm, had assumed the primary caring and parenting responsibility since birth, and understood the child's health-related needs since birth. Interview transcripts were thematically analyzed.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Twenty-four primary caregivers were interviewed. Delaying delivery from sPTL onset was the clinical outcome most associated with a successful intervention for sPTL and considered most important by caregivers due to anticipated subsequent fetal, neonatal, and maternal benefits (which were also perceived as distinct benefits of an intervention). One to two days was typically considered the threshold defining a meaningful delay to delivery from sPTL onset. Additionally, caregivers did not view the individual components of the neonatal morbidity and mortality composite endpoint (historically used to measure clinical benefit in trials of sPTB interventions) as equally relevant to their children's experiences, or as equally important due to perceived differences in their severity and potential for causing further health complications.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;This study centralizes the primary caregiver's voice regarding which clinical outcomes are most important and appropriate to measure for the demonstration of meaningful clinical benefit in interventional studies assessing the delay or prevention of sPTB. Specifically, caregivers perceived delaying delivery from sPTL onset, typically by a minimum of one or two days, as the most important clinical outcome. The findings confirm an unmet need for such interventions, provide a benchmark for defining a patient-perceived clinically meaningful time to delivery from sPTL onset, and establish the inadequacy of the traditional neonatal morbidity and mortality composite endpoint from the care","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":" ","pages":"101701"},"PeriodicalIF":3.8,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144095138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Letter to Editor regarding ' Proximate cord insertion in monochorionic twins with selective fetal growth restriction': Proximate Cord Insertion and Its Hidden Challenges in Monochorionic Twin Pregnancies.","authors":"Ruijuan Chen, Jingni Zhao, Binglin Li","doi":"10.1016/j.ajogmf.2025.101699","DOIUrl":"https://doi.org/10.1016/j.ajogmf.2025.101699","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":" ","pages":"101699"},"PeriodicalIF":3.8,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144086590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Sleep during pregnancy: A Systematic Review of Racial and Ethnic Disparities and Associations to Experiences of Discrimination.","authors":"Zhiqi Zhang, Jaimie Lee, Anita Kiafar, Marie-Hélène Pennestri, Claudia Lugo-Candelas","doi":"10.1016/j.ajogmf.2025.101688","DOIUrl":"https://doi.org/10.1016/j.ajogmf.2025.101688","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;Sleep is critical to perinatal health, with poor quality and short sleep duration in pregnancy being associated to adverse maternal outcomes (e.g., preterm birth, preeclampsia, depression), as well as increased risk for poor offspring outcomes (e.g., lower birthweight, risk for neurodevelopmental disorders). However, a growing body of work documents the existence of ethnic and racial sleep health disparities, but no reviews have examined disparities during pregnancy, a period where sleep is critical for health of the pregnant person and offspring and where stark disparities in pregnancy and delivery outcomes are also observed. We reviewed the available evidence regarding racial/ethnic disparities in prenatal sleep health and the association between exposure to racial/ethnic discrimination and prenatal sleep, a potential mechanism underlying disparities.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Data sources: &lt;/strong&gt;PubMed, MEDLINE, EMBASE, PsycINFO, CINAHL, and ClinicalTrials.gov were searched from inception until November 3, 2023.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Study eligibility criteria: &lt;/strong&gt;Peer-reviewed quantitative studies that examined 1) racial/ethnic disparities in sleep and/or 2) associations between exposure to racial/ethnic discrimination in the prenatal period.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Study appraisal and synthesis methods: &lt;/strong&gt;The present systematic review conducted a narrative synthesis and used the National Heart, Lung, and Blood Institute Quality Assessment tool for Observational Cohort and Cross-sectional Studies.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Eighteen studies were included: 12 found disparities, three did not, and three documented associations between experiences of discrimination and sleep. Overall, African American/Black pregnant persons were found to experience shorter sleep duration and poorer quality, compared to White persons. Studies yielded mixed findings when examining sleep disturbances, latency, and insomnia symptoms. Findings were mixed for Hispanic/Latine persons, with some studies finding increased risk for short and long sleep duration and both increased and decreased sleep disruptions. Studies of other racial/ethnic groups were too few to draw conclusions. Associations between experiencing racial/ethnic discrimination and poorer prenatal sleep were documented across the three studies that examined the topic, but two studies had overlapping samples, precluding from conclusions.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Studies suggest ethnic/racial disparities in prenatal sleep, emphasizing the need for targeted interventions and support. However, important gaps remain, including poor consideration of covariates like socioeconomic status and maternal age, health conditions, and depression. Yet, studies that controlled for socioeconomic status documented disparities, suggesting disparities persist when factors like educational attainment and income are considered. There was considerable variety in how sleep was measured, contributi","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":" ","pages":"101688"},"PeriodicalIF":3.8,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144086596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Continuing the discussion regarding 'Nonsevere hypertensive disorders of pregnancy and oral antihypertensive medications: an argument against use'.","authors":"Laurie B Griffin, Rachel Sinkey, Alan Tita, Dwight J Rouse","doi":"10.1016/j.ajogmf.2025.101703","DOIUrl":"https://doi.org/10.1016/j.ajogmf.2025.101703","url":null,"abstract":"","PeriodicalId":36186,"journal":{"name":"American Journal of Obstetrics & Gynecology Mfm","volume":" ","pages":"101703"},"PeriodicalIF":3.8,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144086585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}